Shenouda Maged
SEC CIK 1658369 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS, INC. | CFO | 1.00M | $2.36M | — | 6 | 2024-01-29 | 2026-09-09 |
Most active insiders at RLMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shenouda Maged | CFO | $1.99M | — |
| 2 | TRAVERSA SERGIO | CEO, Dir | $1.54M | — |
| 3 | Ence Chuck | CAO, COO | $299.2K | — |
| 4 | Kelly Paul Edward | COO, Dir | $198.0K | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-11 07:30 | 2026-09-09+ | RLMD | RELMADA THERAPEUTICS, INC. | Shenouda Maged | CFO | P - Purchase | $4.22 | +200.0K | 1.00M | +25% | +$844.0K |
| D | 2025-12-16 | 2025-12-15 | RLMD | RELMADA THERAPEUTICS, INC. | Shenouda Maged | CFO | P - Purchase | $4.12 | +11.7K | 800.0K | +1% | +$48.1K |
| 2025-11-06 | 2025-11-05 | RLMD | RELMADA THERAPEUTICS, INC. | Shenouda Maged | CFO | P - Purchase | $2.20 | +500.0K | 788.3K | +173% | +$1.10M | |
| M | 2025-05-20 | 2025-05-16+ | RLMD | RELMADA THERAPEUTICS, INC. | Shenouda Maged | CFO | P - Purchase | $0.4865 | +200.0K | 288.3K | +226% | +$97.3K |
| M | 2024-09-11 | 2024-09-09+ | RLMD | RELMADA THERAPEUTICS, INC. | Shenouda Maged | CFO | P - Purchase | $2.80 | +53.4K | 64.2K | +496% | +$149.7K |
| M | 2024-01-31 | 2024-01-29+ | RLMD | RELMADA THERAPEUTICS, INC. | Shenouda Maged | CFO | P - Purchase | $3.85 | +32.7K | 28.0K | New | +$125.7K |
Purchase Sale Sale after option exercise All abbreviations